Press release
Eczema Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Arcutis, Arjil, AstraZeneca, BiomX, Brickell, Dermira, GlaxoSmithKline, Kymab, Kyowa Kirin, LEO Pharma, SCM Lifescience
"Eczema Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Eczema Therapeutics Market.
The report provides a detailed description of the Eczema drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Eczema Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Eczema Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Eczema therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Eczema treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Eczema drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Eczema treatment market.
Learn More about the Clinical and Commercial Development Activities in the Eczema Therapeutics Domain @
https://www.delveinsight.com/report-store/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Eczema Therapeutics Analysis
There are approx. 100+ key companies developing therapies for Eczema. Currently, LEO Pharma is leading the therapeutics market with its Eczema drug candidates in the most advanced stage of clinical development.
Eczema Companies in the Therapeutics Market Include:
• Arcutis Biotherapeutics
• Arjil Pharmaceuticals
• AstraZeneca
• BiomX
• Brickell Biotech Inc
• Dermira
• GlaxoSmithKline
• Kymab
• Kyowa Kirin
• LEO Pharma
• SCM Lifescience
• Sun Pharmaceutical Industries
• UCB Biopharma
And many others
Emerging and Marketed Eczema Therapies Covered in the Report Include:
• Amlitelimab: Kymab
• BX 005: BiomX
• LP 0145: LEO Pharma
And many more
Get an in-depth Assessment of the Emerging Therapies and Eczema Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Eczema Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Eczema pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
Request for Sample PDF to Understand More About the Eczema Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Eczema Current Treatment Patterns
4. Eczema - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Eczema Late-Stage Products (Phase-III)
7. Eczema Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Eczema Discontinued Products
13. Eczema Product Profiles
14. Eczema Companies
15. Eczema Drugs
16. Dormant and Discontinued Products
17. Eczema Unmet Needs
18. Eczema Future Perspectives
19. Eczema Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/eczema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Tenosynovitis Market
https://www.delveinsight.com/report-store/tenosynovitis-market
Checkpoint Inhibitor Refractory Cancer Market
https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market
Encephalomyelitis Market
https://www.delveinsight.com/report-store/encephalomyelitis-market
FENEBRUTINIB Market
https://www.delveinsight.com/report-store/fenebrutinib-emerging-insight-and-market-forecast
Non-Muscle Invasive Bladder Cancer Market
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
Nrg1 Fusion Cancer Pipeline Insight
https://www.delveinsight.com/report-store/nrg1-fusion-cancer-pipeline-insight
Acute Pyelonephritis Market
https://www.delveinsight.com/report-store/acute-pyelonephritis-market
Chronic Refractory Gout Market
https://www.delveinsight.com/report-store/chronic-refractory-gout-market
Complicated Urinary Tract Infections Market
https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market
Congestive Heart Failure (CHF) Market
https://www.delveinsight.com/report-store/congestive-heart-failure-market
Glomerulonephritis Market
https://www.delveinsight.com/report-store/glomerulonephritis-market
Metastatic Uveal Melanoma (MUM) Market
https://www.delveinsight.com/report-store/metastatic-uveal-melanoma-mum-market
Musculoskeletal Pain Market
https://www.delveinsight.com/report-store/musculoskeletal-pain-market
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market
Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market
Limb Girdle Muscular Dystrophy (LGMD) Market
https://www.delveinsight.com/report-store/limb-girdle-muscular-dystrophy-lgmd-market
Lower-Limb Spasticity Market
https://www.delveinsight.com/report-store/lower-limb-spasticity-market
Hemiplegia Market
https://www.delveinsight.com/report-store/hemiplegia-market
Global Kinase Inhibitor in Autoimmune Diseases Market
https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market
Hereditary Spastic Paraplegias Market
https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
Amebiasis Market
https://www.delveinsight.com/report-store/amebiasis-market
Galactosemia Market
https://www.delveinsight.com/report-store/galactosemia-market
Generalized Pustular Psoriasis Market
https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market
Hepatic Impairment Market
https://www.delveinsight.com/report-store/hepatic-impairment-market
Tuberous Sclerosis Complex Market
https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market
Amyloidosis Market
https://www.delveinsight.com/report-store/amyloidosis-market
BRAF-Mutant Metastatic Melanoma Market
https://www.delveinsight.com/report-store/braf-mutant-metastatic-melanoma-market
Candidemia Market
https://www.delveinsight.com/report-store/candidemia-market
Hepatitis D Market
https://www.delveinsight.com/report-store/hepatitis-d-market
Hyperkalemia Market
https://www.delveinsight.com/report-store/hyperkalemia-market
Vasomotor symptoms (Hot flashes/Night sweats) Market
https://www.delveinsight.com/report-store/vasomotor-symptoms-market
Balloon Valvuloplasty Device Market
https://www.delveinsight.com/report-store/balloon-valvuloplasty-market
Choroideremia Market
https://www.delveinsight.com/report-store/choroideremia-market
Chronic Hand Eczema Market
https://www.delveinsight.com/report-store/chronic-hand-eczema-market
Complex Regional Pain Syndrome Market
https://www.delveinsight.com/report-store/complex-regional-pain-syndrome-crps-market
Diffuse Large B-cell Lymphoma Market
https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
Hypersomnia Market
https://www.delveinsight.com/report-store/hypersomnia-market
Lamellar Ichthyosis (LI) Market
https://www.delveinsight.com/report-store/lamellar-ichthyosis-market
Ulcerative Colitis (UC) Market
https://www.delveinsight.com/report-store/ulcerative-colitis-uc-market
Vernal Keratoconjunctivitis Market
https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market-insight
Endocarditis Market
https://www.delveinsight.com/report-store/endocarditis-market
Essential Thrombocythemia (ET) Market
https://www.delveinsight.com/report-store/essential-thrombocythemia-et-market-insights
Hepatorenal Syndrome Market
https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
Pancreatic Ductal Carcinoma Market
https://www.delveinsight.com/report-store/pancreatic-ductal-carcinoma-market
Tenosynovial Giant Cell Tumors (TSGCTs) Market
https://www.delveinsight.com/report-store/tenosynovial-giant-cell-tumors-tsgcts-market
Trauma Fixation Devices Market
https://www.delveinsight.com/report-store/trauma-devices-market
Usher Syndrome Market
https://www.delveinsight.com/report-store/usher-syndrome-market
Vulvar Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/vulvar-squamous-cell-carcinoma-market
Wide Neck Bifurcation Intracranial Aneurysms Market
https://www.delveinsight.com/report-store/wide-neck-bifurcation-intracranial-aneurysms-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eczema Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Arcutis, Arjil, AstraZeneca, BiomX, Brickell, Dermira, GlaxoSmithKline, Kymab, Kyowa Kirin, LEO Pharma, SCM Lifescience here
News-ID: 3257410 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Eczema
Codex Labs to Exhibit at the National Eczema Association's Eczema Expo 2025
Scottsdale, Ariz. - July 17th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in the National Eczema Association's Eczema Expo 2025 [https://nationaleczema.org/eczema-expo/?gad_source=1&gad_campaignid=22351487646&gbraid=0AAAAAB0npNbWbfjE80zPi-DhIw2YfY2qF&gclid=CjwKCAjw3f_BBhAPEiwAaA3K5GPLZHZHEl6Qy8xrAj3hEWhfW7WDsCE-7pymOFKmLfLmr43e1AAXYhoC90YQAvD_BwE]. Taking place from July 24th to 27th at the Grand Hyatt Scottsdale Resort, individuals impacted by eczema will gather to learn from world-class medical experts and community leaders. The goal of the event is to provide you with support,…
Global Parents for Eczema Research (GPER) Awards Two Grants to Advance Childhood …
Santa Barbara, CA, October 15, 2024 - Global Parents for Eczema Research (GPER), a nonprofit organization dedicated to improving the lives of children suffering from eczema (atopic dermatitis, AD), announced the funding of two groundbreaking research projects as part of its 2024 Childhood Eczema Prevention Grant program. These grants will each provide up to $25,000 to support clinical research focused on preventing eczema in children.
Eczema affects up to 20% of…
"BIG IDEAS FOR ECZEMA RESEARCH CHALLENGE" WINNERS ANNOUNCED
Three parents of children with eczema win top prizes for their innovative ideas for research based on their "lived experience".
Santa Barbara, CA, May 23, 2024 - Global Parents for Eczema Research is pleased to announce the winners of its annual "Big Ideas for Eczema Challenge", a global contest that rewards patients and their caregivers for their novel ideas for eczema research. The goal is to improve the understanding of eczema,…
Global Parents for Eczema Research (GPER) Announces Childhood Eczema Prevention …
Santa Barbara, CA, March 11, 2024 - Global Parents for Eczema Research (GPER) today announced the release of its Childhood Eczema Prevention Grant aimed at supporting innovative research studies focused on preventing pediatric atopic dermatitis (AD or "eczema"). This funding announcement is aimed at addressing the increasing prevalence of AD among children and at fostering research initiatives with the potential to mitigate the burden on children and families.
"We are dedicated…
Eczema Treatment Market During 2017 to 2025
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.…
Eczema Treatment Market: Latest Trends & Insights 2025
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.…
